Your trusted source for GLP-1 research, news, and patient insights.
4 posts in this category
We're working hard to keep things updated but give us some grace as providers potentially change their offerings around tirzepatide.
We’ve all been hearing about the shortage of tirzepatide or semaglutide, but what is a shortage? How does it impact compounding?
The FDA has ended the shortage for tirzepatide, essential copy compounding ends on Feb 18 and March 19
November 21 joint status report on the OFA vs FDA lawsuit over compounded tirzepatide availability and the FDA's ongoing reevaluation.
